Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice
- PMID: 28964912
- PMCID: PMC5645257
- DOI: 10.1016/j.bbr.2017.09.043
Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice
Abstract
Recent genetic analyses have provided evidence that clinical commonalities associated with different psychiatric diagnoses often have shared mechanistic underpinnings. The development of animal models expressing functional genetic variation attributed to multiple disorders offers a salient opportunity to capture molecular, circuit and behavioral alterations underlying this hypothesis. In keeping with studies suggesting dopaminergic contributions to attention-deficit hyperactivity disorder (ADHD), bipolar disorder (BPD) and autism spectrum disorder (ASD), subjects with these diagnoses have been found to express a rare, functional coding substitution in the dopamine (DA) transporter (DAT), Ala559Val. We developed DAT Val559 knock-in mice as a construct valid model of dopaminergic alterations that drive multiple clinical phenotypes, and here evaluate the impact of lifelong expression of the variant on impulsivity and motivation utilizing the 5- choice serial reaction time task (5-CSRTT) and Go/NoGo as well as tests of time estimation (peak interval analysis), reward salience (sucrose preference), and motivation (progressive ratio test). Our findings indicate that the DAT Val559 variant induces impulsivity behaviors that are dependent upon the reward context, with increased impulsive action observed when mice are required to delay responding for a reward, whereas mice are able to withhold responding if there is a probability of reward for a correct rejection. Utilizing peak interval and progressive ratio tests, we provide evidence that impulsivity is likely driven by an enhanced motivational phenotype that also may drive faster task acquisition in operant tasks. These data provide critical validation that DAT, and more generally, DA signaling perturbations can drive impulsivity that can manifest in specific contexts and not others, and may rely on motivational alterations, which may also drive increased maladaptive reward seeking.
Keywords: Attention-deficit hyperactivity disorder; Dopamine transporter; Impulsivity; Instrumental learning; Motivation; Transgenic model.
Copyright © 2017 Elsevier B.V. All rights reserved.
Figures




Similar articles
-
Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the In Vivo Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559.J Neurosci. 2018 Jun 6;38(23):5302-5312. doi: 10.1523/JNEUROSCI.0055-18.2018. Epub 2018 May 8. J Neurosci. 2018. PMID: 29739866 Free PMC article.
-
Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model.J Neurodev Disord. 2017 Dec 28;9(1):38. doi: 10.1186/s11689-017-9215-8. J Neurodev Disord. 2017. PMID: 29281965 Free PMC article.
-
Single Quantum Dot Imaging Reveals PKCβ-Dependent Alterations in Membrane Diffusion and Clustering of an Attention-Deficit Hyperactivity Disorder/Autism/Bipolar Disorder-Associated Dopamine Transporter Variant.ACS Chem Neurosci. 2019 Jan 16;10(1):460-471. doi: 10.1021/acschemneuro.8b00350. Epub 2018 Sep 11. ACS Chem Neurosci. 2019. PMID: 30153408 Free PMC article.
-
Leaky lessons learned: Efflux prone dopamine transporter variant reveals sex and circuit specific contributions of D2 receptor signalling to neuropsychiatric disease.Basic Clin Pharmacol Toxicol. 2024 Feb;134(2):206-218. doi: 10.1111/bcpt.13964. Epub 2023 Dec 6. Basic Clin Pharmacol Toxicol. 2024. PMID: 37987120 Review.
-
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.Neurochem Int. 2014 Jul;73:56-70. doi: 10.1016/j.neuint.2013.11.009. Epub 2013 Dec 8. Neurochem Int. 2014. PMID: 24332984 Free PMC article. Review.
Cited by
-
Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter.Behav Brain Res. 2021 Jun 25;408:113267. doi: 10.1016/j.bbr.2021.113267. Epub 2021 Mar 29. Behav Brain Res. 2021. PMID: 33794225 Free PMC article.
-
Male DAT Val559 Mice Exhibit Compulsive Behavior under Devalued Reward Conditions Accompanied by Cellular and Pharmacological Changes.Cells. 2022 Dec 15;11(24):4059. doi: 10.3390/cells11244059. Cells. 2022. PMID: 36552823 Free PMC article.
-
Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders.Mol Neurobiol. 2025 Feb;62(2):2420-2434. doi: 10.1007/s12035-024-04418-8. Epub 2024 Aug 7. Mol Neurobiol. 2025. PMID: 39110391 Review.
-
Diabetes type 2 risk gene Dusp8 is associated with altered sucrose reward behavior in mice and humans.Brain Behav. 2021 Jan;11(1):e01928. doi: 10.1002/brb3.1928. Epub 2020 Nov 1. Brain Behav. 2021. PMID: 33131190 Free PMC article.
-
Dopamine neurons do not constitute an obligatory stage in the final common path for the evaluation and pursuit of brain stimulation reward.PLoS One. 2020 Jun 5;15(6):e0226722. doi: 10.1371/journal.pone.0226722. eCollection 2020. PLoS One. 2020. PMID: 32502210 Free PMC article.
References
-
- Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366(9481):237–248. - PubMed
-
- Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. The American journal of psychiatry. 2007;164(6):942–948. - PubMed
-
- Wu J, Xiao H, Sun H, Zou L, Zhu LQ. Role of dopamine receptors in ADHD: a systematic meta-analysis. Molecular neurobiology. 2012;45(3):605–620. - PubMed
-
- Swanson J, Oosterlaan J, Murias M, Schuck S, Flodman P, Spence MA, et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(9):4754–4759. - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases